Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novartis reported $842M in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
AstraZeneca AZN:LN USD 387M 0
Bausch Health Companies Inc VRX:CN USD 10.4B 14M
Catalent CTLT:US USD 2M 0
Corcept Therapeutics CORT:US USD 131K 0
Drreddys Laboratories RDY:US INR 833M 0
Eli Lilly LLY:US USD 593.5M 600K
Endo International ENDP:US USD 67K 0
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
Glaxosmithkline GSK:US GBP 1.35B 1000K
Horizon Pharma HZNP:US USD 23K 0
J&J JNJ:US USD 3.12B 0
Novartis NOVN:VX USD 842M 48M
Pacira PCRX:US USD 46K 0
Perrigo PRGO:US USD 6.91B 25.9M
Phibro Animal Health PAHC:US USD 4K 0
Prestige Brands PBH:US USD 548K 0
Roche Holding ROG:VX CHF 107M 0
Supernus Pharmaceuticals SUPN:US USD 54K 0
Zoetis ZTS:US USD 5M 0